NervGen Pharma Corp. Common stock
General ticker "NGEN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $243.9M (TTM average)
NervGen Pharma Corp. Common stock does not follow the US Stock Market performance with the rate: -31.7%.
Estimated limits based on current volatility of 3.6%: low 1.29$, high 1.38$
Factors to consider:
- Earnings expected soon, date: 2026-11-12 bmo
Short-term NGEN quotes
Long-term NGEN plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | CA$0.00MM | CA$0.00MM | CA$0.00MM |
| Operating Expenses | CA$17.78MM | CA$24.92MM | CA$25.08MM |
| Operating Income | CA$-17.78MM | CA$-24.92MM | CA$-25.08MM |
| Non-Operating Income | CA$-4.61MM | CA$0.93MM | CA$-19.04MM |
| R&D Expense | CA$8.00MM | CA$15.66MM | CA$13.91MM |
| Income(Loss) | CA$-22.38MM | CA$-23.99MM | CA$-44.12MM |
| Net Income(Loss)* | CA$-22.38MM | CA$-23.99MM | CA$-44.12MM |
| Stockholders Equity | CA$-2.01MM | CA$2.57MM | CA$3.48MM |
| Assets | CA$13.24MM | CA$19.47MM | CA$23.21MM |
| Operating Cash Flow | CA$-11.30MM | CA$-16.83MM | CA$-19.50MM |
| Capital expenditure | CA$0.01MM | CA$0.00MM | CA$0.00MM |
| Investing Cash Flow | CA$-0.14MM | CA$0.06MM | CA$0.10MM |
| Financing Cash Flow | CA$0.77MM | CA$22.68MM | CA$23.76MM |
| Earnings Per Share** | CA$-0.38 | CA$-0.36 | CA$-0.61 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.